Spironolactone is frequently prescribed with ACE inhibitors (e.g., perindopril and zofenopril in our dataset) and with angiotensin receptor blockers (e.g., candesartan cilexetil), combinations that increase the likelihood of hyperkalemia. This evidence concerns the gene ACE and Hyperkalemia.